Occudo Quantitative Strategies LP Xeris Biopharma Holdings, Inc. Transaction History
Occudo Quantitative Strategies LP
- $757 Million
- Q3 2025
A detailed history of Occudo Quantitative Strategies LP transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 47,674 shares of XERS stock, worth $345,636. This represents 0.05% of its overall portfolio holdings.
Number of Shares
47,674
Previous 179,354
73.42%
Holding current value
$345,636
Previous $837,000
53.88%
% of portfolio
0.05%
Previous 0.1%
Shares
6 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...